Collaborative enzyme study could lead to a target for cancer therapeutics
A new study into the enzyme Cdc34 may make it possible to target the enzyme specifically to develop new cancer therapeutics.
List view / Grid view
A new study into the enzyme Cdc34 may make it possible to target the enzyme specifically to develop new cancer therapeutics.
A drug discovery platform for mental health treatment could also help to identify mechanisms for the treatment of substance use disorders.
A simple and direct method of introducing lipids into protein has been developed using palladium as a catalyst.
Cells containing Meflin play a role in restraining the progression of pancreatic cancer and could lead to new therapies against the disease.
A new platform has the potential to better understand what dictates the invasive behaviour of brain tumours.
A genetic mutation that causes idiopathic pulmonary fibrosis has been identified and could lead to a new therapeutic approach to treating the disease.
A new algorithm has been developed which personalises which cancer mutations are best targets for immunotherapy.
A new study has shown the possibility of using RNA splicing as a potential molecular target for Alzheimer's disease.
Gene therapy for the treatment of Duchenne muscular dystrophy has safely stopped the muscle deterioration associated with the disease.
New protein-painting technology could lead to developing cancer immunotherapy medicines that can be administered as a pill.
A world-first compound that can keep cells alive and functioning in a healthy state could be revolutionary for medical emergencies.
Researchers have identified a protein on the surface of cells that cause MS and have used antibodies as an effective treatment for the condition in mice.
Researchers have imaged an inflammation-related protein receptor on cell membranes which could inform future drug designs to prevent cell death.
Researchers have uncovered a treatment that may be used to treat heart attacks or to prevent heart failure, using the circadian clock.
A study has demonstrated that blocking certain receptors in mice reduced Ewing sarcoma growth and metastasis, which could be used within future treatments.